Tylenol and Lubiprostone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tylenol (acetaminophen) and Lubiprostone (lubiprostone). Common drug interactions include abdominal pain lower among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Tylenol and Lubiprostone. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Tylenol?

Tylenol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 222,309 Tylenol users. Check the latest studies of Tylenol.

What is Lubiprostone?

Lubiprostone has active ingredients of lubiprostone. eHealthMe is studying from 957 Lubiprostone users. Check the latest studies of Lubiprostone.



On Jul, 11, 2026

34 people who take Tylenol and Lubiprostone together, and have interactions are studied.

Tylenol and Lubiprostone drug interactions.

What are the common drug interactions of Tylenol and Lubiprostone, by gender? *:

female:

  1. Abdominal pain lower
  2. Abnormal faeces (abnormal stool)
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Blood creatinine increased
  5. Blood potassium decreased
  6. Blood pressure diastolic increased
  7. Blood pressure increased
  8. Blood urea increased
  9. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  10. Bone pain

male:

  1. Acute respiratory failure
  2. Constipation
  3. Atelectasis (partial or complete collapse of the lung)
  4. Dyspnoea (difficult or laboured respiration)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Cough
  7. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Oropharyngeal pain

What are the common drug interactions of Tylenol and Lubiprostone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Arthralgia (joint pain)
  2. Diarrhoea
  3. Infectious mononucleosis (infection usually caused by the epstein-barr virus)
  4. Cough
  5. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  6. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Oropharyngeal pain
  9. Pyrexia (fever)
  10. Rhinovirus infection

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Nephrolithiasis (calculi in the kidneys)
  4. Nephropathy (damage to or disease of a kidney)
  5. Renal failure (kidney dysfunction)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

40-49:

n/a

50-59:

  1. Flushing (the warm, red condition of human skin)
  2. Glycosylated haemoglobin increased
  3. Hepatic enzyme increased
  4. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  5. Nausea (feeling of having an urge to vomit)
  6. Oral discomfort (pain or irritation in mouth)
  7. Psychological trauma
  8. Respiratory tract infection
  9. Weight decreased
  10. Constipation

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Acute respiratory failure
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Brain natriuretic peptide increased
  6. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  7. Drug intolerance (drug sensitivity)
  8. Hangover
  9. Hypervolaemia (abnormally increased volume of blood)
  10. Hypoacusis (loss of hearing)

What are the existing conditions these people have? *

  1. Depression: 12 people, 35.29%
  2. Constipation: 12 people, 35.29%
  3. High Blood Pressure: 12 people, 35.29%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 26.47%
  5. Nausea (feeling of having an urge to vomit): 9 people, 26.47%
  6. Stress And Anxiety: 8 people, 23.53%
  7. Fever: 7 people, 20.59%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 17.65%
  9. Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 5 people, 14.71%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 14.71%

* Approximation only. Some reports may have incomplete information.

Do you take Tylenol and Lubiprostone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tylenol and Lubiprostone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tylenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lubiprostone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tylenol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lubiprostone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen and lubiprostone (the active ingredients of Tylenol and Lubiprostone, respectively), and Tylenol and Lubiprostone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: